Drawing for GENOME THERAPEUTICS

USPTO serial 75922263

GENOME THERAPEUTICS

Reviewed by CopyMark Law Group

Reg. 2699145Status 710
Filing date
Status date
Registration date
Mar 25, 2003
Examiner
BELL, MARLENE D
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with GENOME THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nina L. Pearlmutter

NINA L PEARLMUTTER GENOME THERAPEUTICS CORPORATION100 BEAVER STWALTHAM, MA 02453-8425UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals, namely, pharmaceutical compounds, therapeutic agents and other biotechnologic substances incorporating the results of genomic research, namely, drugs and anti-infective agents for combating resistant infectious diseases for human and veterinary applications; biotechnological compounds and substances designed to provide functional assay of genes, perform gene sequencing and assist in genetic mapping and analysis of human and animal genomesSECTION 8 - CANCELLED—
009Scientific instruments, namely, instruments, substances and compounds designed to, singly or in combination, provide functional assays of genes, perform gene sequencing and assist in genetic mapping and analysis of human genomes and the likeSECTION 8 - CANCELLEDSep 1, 1994
042Biotechnology research and development services in the field of genome research, including genetic mapping of genetic and infectious diseases, SNP detection performing functional assays of genes, sequencing genes and the likeSECTION 8 - CANCELLEDSep 1, 1994

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 1, 2009C8..CANCELLED SEC. 8 (6-YR)—
Apr 30, 2008CFITCASE FILE IN TICRS—
Mar 25, 2003R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 31, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 11, 2002NPUBNOTICE OF PUBLICATION—
Nov 8, 2002EXPTEXPARTE APPEAL TERMINATED—
Oct 17, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 11, 2002CNEAEXAMINERS AMENDMENT MAILED—
Aug 28, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 28, 2002MAILPAPER RECEIVED—
Feb 28, 2002RECGACTION GRANTING REQ. FOR RECON. MAILED—
Jan 30, 2002JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Jan 30, 2002EXPIEX PARTE APPEAL-INSTITUTED—
Jan 7, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 5, 2001CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 5, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 2, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 1, 2000DOCKASSIGNED TO EXAMINER—
Jul 31, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 21, 2000DOCKASSIGNED TO EXAMINER—
Jul 21, 2000DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance